NCT00195585已完成3 期
Post-Approved Phase III Study of 1-LV/5FU Therapy
Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点 分布在 1 个国家目标入组 650 人开始时间: 2002年10月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 650
- 试验地点
- 1
- 主要终点
- Relapse-free survival time
研究概览
简要总结
The purpose of the study is to verify superiority of 1-LV/5FU therapy to UFT Therapy of relapse-free survival time in patients with Dukes C and Cure A colon cancer. Secondary endpoints include disease-free survival time, survival time, and safety.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Dukes C, Cure A colon cancer diagnosed histologically or cytologically
- •Normal organ function of bone marrow, heart, liver and kidney
- •Age 20-75
- •Other inclusion applies
排除标准
- •Serious bone marrow suppression, infection, heart disease or complication
- •Familial adenomatous polyposis or hereditary nonpolyposis
- •Pregnant or breastfeeding women
- •Other exclusion applies
结局指标
主要结局
Relapse-free survival time
次要结局
- Disease-free survival time, survival time, safety
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study Evaluating Isovorin in Advanced/Recurrent Gastric CancerGastric CancerNCT00195572Wyeth is now a wholly owned subsidiary of Pfizer200
已完成
3 期
A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)Colorectal NeoplasmsNCT00190515Haruhiko Fukuda1,101
Unknown
3 期
Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal CancerColorectal CancerNCT00497107Iwate Medical University300
已完成
1 期
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell CarcinomaKidneyCancerNCT00277017New Mexico Cancer Research Alliance15
Unknown
1 期
Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic DermatitisAtopic DermatitisNCT04725136Kang Stem Biotech Co., Ltd.96